Related Experiment Videos
The human cytochrome P4507B1: catalytic activity studies
Sae-Bom Kim1, Sonia Chalbot, Denis Pompon
1Laboratoire de Biotechnologie, Conservatoire National des Arts et Métiers (CNAM), EA-3199, 2 rue Conté, Paris 75003, France.
The Journal of Steroid Biochemistry and Molecular Biology
|February 9, 2005
Summary
Cytochrome P4507B1 (P4507B1) in the human brain produces neurosteroids with potential neuroprotective effects. This study characterized P4507B1 activity and its inhibition by estrogens and beta-amyloid.
Area of Science:
- Neuroendocrinology
- Steroid Metabolism
- Enzymology
Background:
- The human hippocampus contains cytochrome P4507B1 (P4507B1), an enzyme involved in neurosteroid production.
- 7-hydroxylated neurosteroids, derived from dehydroepiandrosterone (DHEA) and other precursors, exhibit neuroprotective properties.
- Understanding P4507B1's activity and regulation is crucial for neurosteroid research.
Purpose of the Study:
- To characterize the kinetic parameters of human P4507B1.
- To investigate the formation of 7alpha- and 7beta-hydroxylated neurosteroid derivatives.
- To determine the inhibitory effects of estrogens and beta-amyloid peptide on P4507B1 activity.
Main Methods:
- Recombinant human P4507B1 was expressed in yeast.
- Microsomal enzyme activity was assessed using NADPH and radiolabeled steroid substrates.
- Kinetic parameters (K(M)) and inhibitor responses were analyzed.
Main Results:
- P4507B1 preferentially hydroxylates dehydroepiandrosterone (DHEA), 5alpha-androstane-3beta,17beta-diol, and epiandrosterone.
- Major product is 7alpha-hydroxylated, with minor amounts of 7beta-hydroxylated derivatives formed.
- Estrogen (estrone, estradiol) and beta-amyloid peptide inhibit P4507B1-mediated 7-hydroxylation.
Conclusions:
- Human P4507B1 catalyzes the 7-hydroxylation of key neurosteroids, with a preference for 7alpha-hydroxylation.
- The enzyme's activity is modulated by both hormonal (estrogens) and pathological (beta-amyloid) factors.
- These findings provide insights into neurosteroid metabolism and potential therapeutic targets in neurological conditions.